anti cancer medicines

ICLUSIG® (ponatinib) is a prescription medicine used to treat adults who have:

Chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) who cannot receive any other tyrosine kinase inhibitor (TKI) medicines.

A specific type of abnormal gene (T315I-positive) chronic phase, accelerated phase, or blast phase CML, or T315I-positive Ph+ all.

Note:

• Each tablet contains ponatinib HCL equivalent to 45 mg ponatinib.
• Dispense attached medication guide